• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肝细胞癌手术切除后nm23-H1表达与疾病复发

nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.

作者信息

Boix L, Bruix J, Campo E, Sole M, Castells A, Fuster J, Rivera F, Cardesa A, Rodes J

机构信息

Liver Unit, Hospital Clínic i Provincial, University of Barcelona, Spain.

出版信息

Gastroenterology. 1994 Aug;107(2):486-91. doi: 10.1016/0016-5085(94)90175-9.

DOI:10.1016/0016-5085(94)90175-9
PMID:8039626
Abstract

BACKGROUND/AIMS: The nm23-H1 gene is thought to act as a metastasis-suppressor gene. This study investigates the relationship between nm23-H1 messenger RNA (mRNA) expression and intrahepatic tumor recurrence after surgical resection of small hepatocellular carcinoma.

METHODS

Seventeen cirrhotic patients with solitary hepatocellular carcinoma < 5 cm underwent surgical resection. In 7 patients, the neoplasm recurred after a 12-month median follow-up, whereas the other 10 patients were free of disease after a 30-month median follow-up. Both groups were similar according to age, sex, etiology, status of the underlying liver, tumor size, and other pathological characteristics of the neoplasm. nm23-H1 mRNA levels were assessed in matched tumor and surrounding cirrhotic liver samples by Northern blot hybridization using a 900-base pair probe, which is a BamHI fragment of pnm23-H1 recombinant complementary DNA clone encoding the nm23-H1 human gene.

RESULTS

Eight of the 10 patients without disease recurrence during follow-up showed nm23-H1 overexpression with an increase ranging between three- and 45-fold when compared with the nontumoral surrounding liver. Only 1 of the 7 patients with tumor recurrence showed higher nm23-H1 mRNA levels in the tumor than in the nonneoplastic sample (P = 0.013).

CONCLUSIONS

nm23 mRNA overexpression in small solitary hepatocellular carcinoma is associated with a lower recurrence rate after surgical resection, suggesting that this gene may participate in the metastatic dissemination of this neoplasm.

摘要

背景/目的:nm23-H1基因被认为是一种转移抑制基因。本研究旨在探讨nm23-H1信使核糖核酸(mRNA)表达与小肝细胞癌手术切除后肝内肿瘤复发之间的关系。

方法

17例患有直径小于5cm的孤立性肝细胞癌的肝硬化患者接受了手术切除。7例患者在中位随访12个月后肿瘤复发,而其他10例患者在中位随访30个月后无疾病复发。两组患者在年龄、性别、病因、基础肝脏状况、肿瘤大小以及肿瘤的其他病理特征方面相似。通过使用900个碱基对的探针进行Northern印迹杂交,在匹配的肿瘤和周围肝硬化肝脏样本中评估nm23-H1 mRNA水平,该探针是编码nm23-H1人类基因的pnm23-H1重组互补DNA克隆的BamHI片段。

结果

随访期间无疾病复发的10例患者中有8例显示nm23-H1过表达,与非肿瘤周围肝脏相比,增加幅度在3至45倍之间。7例肿瘤复发患者中只有1例肿瘤中的nm23-H1 mRNA水平高于非肿瘤样本(P = 0.013)。

结论

小的孤立性肝细胞癌中nm23 mRNA过表达与手术切除后较低的复发率相关,提示该基因可能参与了这种肿瘤的转移扩散。

相似文献

1
nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.小肝细胞癌手术切除后nm23-H1表达与疾病复发
Gastroenterology. 1994 Aug;107(2):486-91. doi: 10.1016/0016-5085(94)90175-9.
2
[Expression of metastasis suppressor gene nm23 in human hepatocellular carcinoma].[转移抑制基因nm23在人肝细胞癌中的表达]
Zhonghua Bing Li Xue Za Zhi. 1996 Apr;25(2):76-8.
3
[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].[乙酰肝素酶和nm23-H1在肝细胞癌中的表达及意义]
Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6.
4
NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.人肝细胞癌中NM23-H1和NM23-H2信使核糖核酸丰度
Cancer Res. 1995 Feb 1;55(3):652-7.
5
Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.乙酰肝素酶和nm23-H1在肝细胞癌中的表达及意义
World J Gastroenterol. 2005 Mar 7;11(9):1378-81. doi: 10.3748/wjg.v11.i9.1378.
6
Significance of nm23 mRNA expression in human hepatocellular carcinoma.nm23信使核糖核酸在人类肝细胞癌中的表达意义
Anticancer Res. 1998 Jan-Feb;18(1B):541-6.
7
Reduced expression and rare genomic alteration of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines.nm23-H1在人肝癌及肝癌细胞系中的表达降低及罕见基因组改变。
J Gastroenterol. 1998 Jun;33(3):368-75. doi: 10.1007/s005350050098.
8
Nm23-H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma.Nm23-H1在肝细胞癌肝内或肝外转移灶中的表达。
Liver. 1998 Oct;18(5):337-42. doi: 10.1111/j.1600-0676.1998.tb00815.x.
9
High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.Nm23-H1基因的高表达与局部结直肠癌进展相关,而非与转移相关。
Br J Cancer. 1994 Nov;70(5):1025-30. doi: 10.1038/bjc.1994.442.
10
Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.人nm23-H1和nm23-H2蛋白在肝细胞癌中的表达
Cancer. 1994 May 1;73(9):2280-4. doi: 10.1002/1097-0142(19940501)73:9<2280::aid-cncr2820730908>3.0.co;2-3.

引用本文的文献

1
NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.NDPKA 不仅是一种转移抑制因子——要意识到它在神经母细胞瘤中具有促进转移的作用。
Lab Invest. 2018 Feb;98(2):219-227. doi: 10.1038/labinvest.2017.105. Epub 2017 Oct 9.
2
Characteristics of a thyroid carcinoma cell line derived from spinal metastasis.源自脊柱转移灶的甲状腺癌细胞系的特征
Biosci Rep. 2016 Dec 9;36(6). doi: 10.1042/BSR20160403. Print 2016 Dec.
3
Nm23/NDP kinases in hepatocellular carcinoma.肝细胞癌中的Nm23/NDP激酶
J Bioenerg Biomembr. 2006 Aug;38(3-4):169-75. doi: 10.1007/s10863-006-9031-4.
4
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.肝细胞癌切除术后复发的危险因素、预防及管理
Ann Surg. 2000 Jul;232(1):10-24. doi: 10.1097/00000658-200007000-00003.
5
Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.使用一种原始的鸡特异性抗体检测胞质Nme1蛋白在人类乳腺癌中的潜在预后价值。
Br J Cancer. 1996 Mar;73(5):630-5. doi: 10.1038/bjc.1996.109.
6
Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series.肝细胞癌与肝硬化。欧洲系列手术治疗结果
Ann Surg. 1996 Mar;223(3):297-302. doi: 10.1097/00000658-199603000-00011.
7
Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.恶性骨肿瘤中nm23蛋白表达的免疫组织化学分析
J Cancer Res Clin Oncol. 1995;121(11):667-73. doi: 10.1007/BF01218525.